{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:21:42Z","timestamp":1783948902642,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ygyno.2013.10.028","type":"journal-article","created":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T02:32:22Z","timestamp":1383100342000},"page":"248-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?"],"prefix":"10.1016","volume":"132","author":[{"given":"Mohamad Nasir","family":"Shafiee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulafshana","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Ariffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafaru","family":"Abu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nunns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Seedhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Atiomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.10.028_bb0005","series-title":"Polycystic ovarian syndrome","first-page":"361","author":"Chang","year":"2002"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovarian syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ygyno.2013.10.028_bb0015","first-page":"403","article-title":"Choric anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9378(16)37277-5","article-title":"The Stein\u2013Leventhal Syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma","volume":"73","author":"Dockerty","year":"1957","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-992926","article-title":"Polycystic ovarian syndrome and endometrial cancer","volume":"26","author":"Navaratnarajah","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0035","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0040","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/humrep\/det049","article-title":"Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up","volume":"28","author":"Gallos","year":"2013","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2004.11.053","article-title":"Altered protein expression in endometrial carcinogenesis","volume":"226","author":"Yoshizaki","year":"2005","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.ygyno.2013.10.028_bb0050","first-page":"719","article-title":"Treatment for early endometrial cancer: cost-effectiveness analysis","volume":"44","author":"Fanning","year":"1999","journal-title":"J Reprod Infant Psychol"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the benefit of metformin use in cancer treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0060","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1055-9965.EPI-04-0871","article-title":"Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0065","series-title":"(PDF 544KB) Series MB1 no.39","article-title":"Cancer statistics registrations: registrations of cancer diagnosed in 2008, England","author":"Office for National Statistics","year":"2010"},{"issue":"3\u20135","key":"10.1016\/j.ygyno.2013.10.028_bb0070","first-page":"113","article-title":"Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells","volume":"126","author":"Wang","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/AOG.0b013e318280a338","article-title":"In reply: risk factors for developing endometrial cancer","volume":"121","author":"Torres","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","article-title":"Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan","volume":"98","author":"Lacey","year":"2008","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2013.10.028_bb0085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/01443610802355817","article-title":"Endometrial atypical hyperplasia and subsequent diagnosis of endometrial cancer: a retrospective audit and literature review","volume":"28","author":"Pennant","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","article-title":"Endometrial hyperplasia and the risk of progression to carcinoma","volume":"63","author":"James","year":"2009","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/j.ygyno.2013.10.028_bb0095","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.10.028_bb0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/PGP.0b013e3181659167","article-title":"Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification","volume":"27","author":"Sherman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09513590600585997","article-title":"Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea","volume":"22","author":"Tingthanatikul","year":"2006","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0110","first-page":"325","article-title":"Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome","volume":"98","author":"Cheung","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0120","first-page":"103","article-title":"Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome","volume":"80","author":"Rudnicka","year":"2009","journal-title":"Ginekol Pol"},{"issue":"10","key":"10.1016\/j.ygyno.2013.10.028_bb0125","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1600-0412.2012.01458.x","article-title":"The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism","volume":"91","author":"Holm","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jmig.2012.05.009","article-title":"Diagnosis and management of endometrial hyperplasia","volume":"19","author":"Amy","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.10.028_bb0135","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2013.10.028_bb0140","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0b013e3181e93330","article-title":"Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy","volume":"116","author":"Reed","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"34","key":"10.1016\/j.ygyno.2013.10.028_bb0145","first-page":"e1","article-title":"Inpatient hysterectomy surveillance in the United States, 2000\u20132004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0150","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1038\/sj.onc.1207751","article-title":"Obesity and cancer","volume":"23","author":"Ehrlich","year":"2004","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ygyno.2013.10.028_bb0155","first-page":"774","article-title":"Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0160","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","article-title":"Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome","volume":"85","author":"Quezada","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0165","first-page":"4281","article-title":"Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A","volume":"63","author":"Dabizzi","year":"2003","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0170","first-page":"191","article-title":"The nature of hyperinsulinaemia (insulin resistance) in endometrial carcinoma: of plasma level of insulin and c-peptide","volume":"46","author":"Bershtein","year":"2000","journal-title":"Vopr Onkol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.10.028_bb0175","doi-asserted-by":"crossref","first-page":"355e1","DOI":"10.1016\/j.ajog.2010.11.033","article-title":"Prospective evaluation of insulin resistance among endometrial cancer patients","volume":"20","author":"Burzawa","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.10.028_bb0180","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-07-2686","article-title":"A prospective evaluation of insulin and insulin like growth factor-I as risk factors of endometrial cancer","volume":"17","author":"Gunter","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.10.028_bb0185","first-page":"i96","article-title":"Endometrial gene expression in women with polycystic ovarian syndrome","volume":"20","author":"Pillay","year":"2005","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0340","doi-asserted-by":"crossref","first-page":"e4274","DOI":"10.1371\/journal.pone.0004274","article-title":"Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes\u2013a potential model for PCOS-related insulin resistance","volume":"4","author":"Allemand","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ygyno.2013.10.028_bb0200","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.fertnstert.2010.01.064","article-title":"Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial","volume":"94","author":"Patel","year":"2010","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0205","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2009.04.034","article-title":"Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia","volume":"145","author":"Erdemoglu","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.10.028_bb0210","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","article-title":"Metabolic syndrome and endometrial cancer risk","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.10.028_bb0215","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/1055-9965.EPI-11-0715","article-title":"Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer","volume":"20","author":"Friedenreich","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9378(90)90838-X","article-title":"Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies","volume":"162","author":"Rubin","year":"1990","journal-title":"Am J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.10.028_bb0225","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1210\/jc.2004-1676","article-title":"Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways","volume":"90","author":"Lathi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1210\/jcem-67-1-144","article-title":"Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer","volume":"67","author":"Nagamani","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.03.008","article-title":"Chemopreventive effects of metformin on obesity-associated endometrial proliferation","author":"Zhang","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/aje\/kwm333","article-title":"Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors","volume":"167","author":"Saltzman","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.10.028_bb0245","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/endo.142.3.7991","article-title":"Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor","volume":"142","author":"Navarro","year":"2001","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.ygyno.2013.10.028_bb0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/jc.2010-1803","article-title":"Metformin treatment exerts anti-invasive and antimetastatic effects in human endometrial carcinoma cells","volume":"96","author":"Tan","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0255","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0260","first-page":"19","article-title":"Activation and significance of the PI3K\/Akt pathway in endometrium with polycystic ovary syndrome patients","volume":"47","author":"Zhang","year":"2012","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.ygyno.2013.10.028_bb0265","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2010-2600","article-title":"Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles","volume":"96","author":"Savaris","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ygyno.2013.10.028_bb0275","first-page":"767","article-title":"Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance","volume":"45","author":"Song","year":"2010","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0280","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2009.06.033","article-title":"Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome","volume":"115","author":"Villavicencio","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2013.10.028_bb0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsbmb.2008.03.031","article-title":"In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"110","author":"Bacallao","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0290","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.AOG.0000269047.46078.28","article-title":"Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium","volume":"110","author":"MacLaughlan","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.10.028_bb0295","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2006.09.003","article-title":"Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"104","author":"Villavicencio","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.10.028_bb0300","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2006.03.029","article-title":"Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"103","author":"Villavicencio","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2013.10.028_bb0305","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1940-6207.CAPR-10-0178","article-title":"Chemoprevention meets glucose control","volume":"3","author":"Engelman","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.ygyno.2013.10.028_bb0315","first-page":"308","article-title":"Molecular action of insulin-sensitizing agents","volume":"56","author":"Kacalska","year":"2005","journal-title":"Endokrynol Pol"},{"issue":"4","key":"10.1016\/j.ygyno.2013.10.028_bb0320","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513590.2012.743010","article-title":"Comparison of antiproliferative effects of metformin and progesterone on estrogen-induced endometrial hyperplasia in rats","volume":"29","author":"Tas","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.10.028_bb0325","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecol Endocrinol"},{"issue":"2pt 2","key":"10.1016\/j.ygyno.2013.10.028_bb0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0b013e3181719b92","article-title":"Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives","volume":"112","author":"Shen","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.10.028_bb0335","author":"Metformin for the Treatment of Endometrial Hyperplasia"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:34:38Z","timestamp":1758771278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813012778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0090825813012778"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}